BIIB
Biogen Inc.
227.60$
+0.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.7% | -4.0% | +7.6% | +0.0% | -0.5% | -1.0% | +8.8% | -7.2% | -7.1% | +8.7% | +10.4% | – | |
| – | -6.3% | -19.4% | +91.9% | -33.2% | -8.6% | -1.0% | +63.7% | -7.4% | -43.4% | +33.2% | +78.3% | – | |
| – | -5.5% | +1.4% | -15.8% | +21.1% | +2.4% | -1.0% | -8.3% | -7.1% | +13.0% | +1.9% | -14.3% | – | |
| – | -18.8% | -19.1% | +13.1% | +13.6% | +1.6% | -20.1% | -2.9% | -30.3% | +37.8% | +12.5% | -13.5% | – | |
| – | -31.9% | +8.3% | -4.8% | +6.2% | +4.0% | -6.4% | +2.0% | +1.9% | +14.8% | -11.1% | +16.9% | – | |
| – | -19.0% | -12.2% | +3.7% | +9.4% | +9.0% | -17.7% | -0.8% | -13.2% | +90.8% | -22.9% | -12.7% | – | |
| – | +59.7% | +34.7% | -46.9% | +57.5% | -11.8% | +43.9% | -19.7% | +4.4% | -109.3% | – | -20.0% | – | |
| – | +12.1% | -3.2% | -11.4% | -2.4% | +0.3% | +0.0% | +21.0% | -7.2% | +0.1% | +0.1% | +21.7% | – | |
| – | – | +59.4% | +50.3% | -35.5% | -35.4% | +6.8% | +139.1% | -25.1% | -137.9% | – | -64.9% | – | |
| – | – | +67.2% | +61.2% | -45.7% | -60.3% | +185.1% | +54.5% | -16.8% | -279.1% | – | -40.0% | – | |
| – | – | +57.5% | +48.3% | -33.4% | -31.4% | -9.8% | +164.0% | -26.5% | -110.4% | – | -69.5% | – | |
| – | +52.0% | +29.7% | +24.2% | -26.2% | -3.2% | +25.1% | +28.3% | -25.5% | -74.3% | +160.9% | -85.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.